Method of administering azithromycin

Patent RE39149 Issued on June 27, 2006.

Patent References

4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents
Patent #: 4382085
Issued on: 05/03/1983
Inventor: Sciavolino , et al.

N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
Patent #: 4474768
Issued on: 10/02/1984
Inventor: Bright

11-Methyl-11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl-7,1 3,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one and derivatives thereof
Patent #: 4517359
Issued on: 05/14/1985
Inventor: Kobrehel , et al.

Azithromycin and derivatives as antiprotozoal agents
Patent #: 4963531
Issued on: 10/16/1990
Inventor: Remington

O-methyl derivatives of azithromycin A
Patent #: 5250518
Issued on: 10/05/1993
Inventor: Kobrehel, et al.

2'-position modified compound of erythromycin or its derivative
Patent #: 5350839
Issued on: 09/27/1994
Inventor: Asaka, et al.

Taste-masking composition of bitter pharmaceutical agents
Patent #: 5633006
Issued on: 05/27/1997
Inventor: Catania, et al.

Controlled-release dosage forms of Azithromycin
Patent #: 6068859
Issued on: 05/30/2000
Inventor: Curatolo, et al.

Azithromycin dihydrate Patent #: 6268489
Issued on: 07/31/2001
Inventor: Allen, et al.

Inventors

Assignee

Pfizer Inc.

Application

No. 11041194 filed on 01/20/2005

US Classes:

514/29, The hetero ring has exactly 13 ring carbons (e.g., erythromycin, etc.)424/464, Tablets, lozenges, or pills424/465, With claimed perfecting feature in contents (e.g., excipient, lubricant, etc.)424/474, Coated pills or tablets424/480, Cellulose or derivative424/482, Containing solid synthetic polymers514/960, SIGNIFICANT, TABLET FORMULATION (E.G., DESIGNATED EXCIPIENT, DISINTEGRANT, GLYDENT OR LUBRICANT, ETC.)536/7.2, Erythromycin or derivative (e.g., oleandomycin, etc.)536/7.4Additional nitrogen containing

Examiners

Primary: Peselev, Elli

Attorney, Agent or Firm

Foreign Patent References

0307128 EP 03/01/1989
0298650 EP 02/01/1992
0307128 EP 04/01/1992
0582396 EP 02/01/1994
0582396 EP 01/01/2001
WO 9509601 WO 04/01/1995

International Classes

A61K 31/70
A61K 9/14
A61K 9/20

Abstract

An oral dosage form of azithromycin which does not exhibit an adverse food effect; Specific azithromycin oral dosage forms including tablets, powders for oral suspensions and unit dose packets; Methods of treating microbial infections with the dosage forms; And therapeutic packages containing the dosage forms.

Other References

Documents relating to the European Patent Office Opposition proceedings regarding EU Patent No. 0 679 400 (Opposition file).
Zithromax (Trademark of Pfizer Inc.) Tablet and Powder for Oral Suspension Package Insert for azithromycin tablets and powder for oral suspension dosage forms sold commercially in Italy (1992).
Russell, T. L., et al., Upper Gastrointestinal pH in Seventy-nine Healthy, Elderly North American Men and Women, Pharmaceutical Research, vol. 10, No. 2, pp. 187-196, (1993).
Toothaker, R. D., et al., The Effect of Food on Drug Bioavailability, Ann. Rev. Pharmacol, Toxicol., vol. 20, pp. 173-199, (1980).
Hopkins, S., Clinical Toleration and Safety of Azithromycin, The American Journal of Medicine, vol. 91 (Suppl. 3A), pp. 40S-45S, (1991).
Chu, S., et. al., Drug-Food Interaction Potential of Clarithromycin, a New Macrolide Antimicrobial, J. Clin. Pharmacol., vol. 32, pp. 32-36, (1992).
Drew, R. H., et. al. Azithromycin—Spectrum of Activity, Pharmacokinetics, and Clinical Applications, Pharmacotheraphy, vol. 12, No. 3, pp. 161-173, (1992).
Malmborg, A., Absorption of erthromycin stearate after oral administration, Curr. Med. Res. Opin., vol. 5, (Suppl. 2)., pp. 15-18, (1978).
Welling, P. G., et. al., Plasma Levels following Single and Repeated Doses of Erythromycin Estolate and Erythromycin Stearate, Journal of Pharmaceutical Sciences, vol. 68, No. 2, pp. 150-155, (1979).
Welling, P. G., et. al., Bioavailability of Erythromycin Stearate: Influence of Food and Fluid Volume, Journal of Pharmaceutical Sciences, vol. 67, No. 6, pp. 764-766, (1978).
Curatolo, et al., Perforated Coated Tablets for Controlled Release of Drugs at a Constant Rate, Journal of Pharmaceutical Sciences, vol. 77, No. 4, pp. 322-324, (1988).
Zithromax (Trademark of Pfizer, Inc.) Capsules Package Insert for azithromycin capsule dosage form sold commercially in U.S.
CA Abstracts: vol. 120:38194a; (1994).